{"disease":{"id":"pure-red-cell-aplasia","name":"pure red cell aplasia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06065852","title":"National Registry of Rare Kidney Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":35000,"lead_sponsor_name":"UK Kidney Association","has_results":false},{"nct_id":"NCT03918265","title":"Tacrolimus Treatment for Refractory Autoimmune Cytopenia","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT03364764","title":"Sirolimus Treatment for Refractory PRCA","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"Bing Han","has_results":false},{"nct_id":"NCT06412497","title":"MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Masonic Cancer Center, University of Minnesota","has_results":false},{"nct_id":"NCT04470804","title":"Sirolimus Treatment for Newly Diagnosed Primary Acquired PRCA","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"Bing Han","has_results":false},{"nct_id":"NCT03333486","title":"Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":31,"lead_sponsor_name":"Roswell Park Cancer Institute","has_results":true},{"nct_id":"NCT03540472","title":"Tacrolimus Treatment for Refractory PRCA","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT00314795","title":"Efficacy and Safety of Peginesatide (AF37702) in the Treatment of Anemia in Participants With Chronic Kidney Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT04423367","title":"Bortezomib Plus Dexamethasone for Acquired Pure Red Cell Aplasia Failure or Relapse After First-line Treatment","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT07031115","title":"Linperlisib in the Treatment of aPRCA","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":15,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT03966053","title":"The Use of Trifluoperazine in Transfusion Dependent DBA","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"Adrianna Vlachos, MD","has_results":true}],"total":11},"guidelines":[],"source":"Drug Landscape verified database"}